OSAM
XERS icon

O'Shaughnessy Asset Management’s Xeris Biopharma Holdings XERS Stock Holding History

O'Shaughnessy Asset Management’s Portfolio XERS Stock Details XERS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-11,423
Closed -$89.7K – 2840
2025
Q4 		$89.7K Buy
11,423
+1,263
+12% +$9.94K ﹤0.01% 2146
2025
Q3 		$82.7K Buy
+10,160
New +$67.5K ﹤0.01% 2129

Other funds holding XERS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

O'Shaughnessy Asset Management's XERS Position: Q1 2026 in Review

O'Shaughnessy Asset Management sold out of Xeris Biopharma Holdings (XERS) in Q1 2026, closing a stake of 11,423 shares — an estimated $89.7K sold.

O'Shaughnessy Asset Management first reported a position in XERS in Q3 2025 and held it in 2 quarters. The position peaked at $89.7K in Q4 2025. 237 funds tracked by Wall St. Rank hold XERS as of Q1 2026.

  • O'Shaughnessy Asset Management reported no remaining Xeris Biopharma Holdings position as of Q1 2026 after selling out during the quarter.
  • O'Shaughnessy Asset Management sold 11,423 Xeris Biopharma Holdings shares in Q1 2026, an estimated $89.7K.
  • O'Shaughnessy Asset Management first reported a position in Xeris Biopharma Holdings in Q3 2025 and held it in 2 quarters.
  • O'Shaughnessy Asset Management's Xeris Biopharma Holdings position peaked at $89.7K in Q4 2025.
  • 237 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q1 2026.

Based on O'Shaughnessy Asset Management's 13F filing for Q1 2026, filed 13 May 2026.